Dan Komarek

VP of Investor Relations @ Bridge Therapeutics Inc.

About

Dan is an experienced entrepreneur, angel investor, and business advisor with over 35 years in the life sciences industry. He has held management positions at numerous early-stage and Fortune 500 life science companies and played an active role in multiple M&A transactions, leading to successful exits with Fortune 500 life science conglomerates. Most recently, Dan served as President of MTI GlobalStem, where he led the company's growth and strategic direction, culminating in its acquisition by Thermo Fisher Scientific. He possesses deep expertise across all facets of life science business operations, including corporate management, cGMP manufacturing, R&D, operations, finance, M&A, sales, and marketing. As an active angel investor, Dan has backed many early-stage companies, primarily within the life sciences sector. He also advises several small and midsize biotech firms, supporting them in M&A, due diligence, fundraising, and defining business strategy.

Country

United States

City

Rockville

Industry

Biotechnology

Skill

Biotechnology, Investor Relations, Strategic Thinking, Biochemistry

Experience

VP of Investor Relations

Bridge Therapeutics Inc.

2025-5 - Present · 1 yr 5 mos

Maryland, United States

Corporate Advisor

Celestial Therapeutics

2025-4 - Present · 1 yr 6 mos

Maryland, United States

Strategic Business Advisor

Life Science Consultant

2018-1 - Present · 8 yrs 9 mos

Angel Investor

Keiretsu Forum

2019-2 - Present · 7 yrs 8 mos

Washington D.C. Metro Area

President/GM of MTI-GlobalStem division

Thermo Fisher Scientific

2016-11 - 2017-11 · 1 yr 1 mo

President of the MTI-GlobalStem Division at Thermo Fisher Scientific

President/COO

MTI-GlobalStem, a part of Thermo Fisher Scientific

2009-11 - 2017-11 · 8 yrs 1 mo

MTI-GlobalStem was acquired by Thermo Fisher Scientific in November of 2016. Manage business and operational activities for MTI-GlobalStem.

Biotechnology Business Advisor

Biotech Consulting

2007-7 - 2009-11 · 2 yrs 5 mos

Washington D.C. Metro Area

Held senior business and R&D consulting positions for a number of Biotech companies, including: -Capsant Neurosciences, Ltd -Expression Pathologies, Inc. -20/20 Genesystems, Inc. -Molecular Transfer, Inc.